LADENBURG THALMANN FINANCIAL SERVICES INC. - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 0.83 and the average weighting 0.3%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$1,000
-85.7%
7,400
-54.9%
0.00%
Q3 2018$7,000
+600.0%
16,400
+4000.0%
0.00%
Q2 2018$1,0000.0%4000.0%0.00%
Q1 2018$1,0000.0%4000.0%0.00%
Q4 2017$1,0000.0%4000.0%0.00%
Q3 2017$1,0000.0%400
-2.4%
0.00%
Q2 2017$1,000
-80.0%
410
-67.8%
0.00%
Q1 2017$5,000
+150.0%
1,273
+89.2%
0.00%
Q4 2016$2,000
-50.0%
673
-35.8%
0.00%
Q3 2016$4,0000.0%1,048
+23.6%
0.00%
Q2 2016$4,000
-20.0%
848
-35.7%
0.00%
Q1 2016$5,000
-79.2%
1,318
-15.7%
0.00%
Q4 2015$24,000
+20.0%
1,563
-16.1%
0.00%
Q3 2015$20,000
-39.4%
1,863
+44.6%
0.00%
-100.0%
Q2 2015$33,000
+37.5%
1,288
+45.0%
0.00%
Q1 2015$24,0000.0%888
-32.5%
0.00%
-100.0%
Q4 2014$24,000
+2300.0%
1,315
+1043.5%
0.00%
Q3 2014$1,000
-98.0%
115
-96.3%
0.00%
-100.0%
Q2 2014$50,000
+35.1%
3,070
+46.2%
0.00%0.0%
Q1 2014$37,000
-19.6%
2,100
+10.5%
0.00%0.0%
Q4 2013$46,000
-89.6%
1,900
-84.7%
0.00%
-93.3%
Q3 2013$441,000
+141.0%
12,450
+6.0%
0.02%
+114.3%
Q2 2013$183,00011,7500.01%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2013
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders